| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Istituto Neurologico C. Besta, Divisione di Biochimica e Genetica, Italy (Drs. Finocchiaro and Di Donato)
Istituto Scientifico S. Raffaele, Cattedra di Clinica Medica, Milan, Italy (Drs. Baio, Micossi, and Pozza).
We have characterized the abnormalities of glucose metabolism associated with Friedreich's ataxia (FA) by studying plasma glucose, insulin, growth hormone (GH), and glucagon before and after an oral glucose tolerance test (OGTT), an IV glucose load, and an IV arginine load, in 21 patients and in controls. Twelve patients were normotolerant (NT) to glucose, five glucose-intolerant (IT), and four diabetic (DM). Insulin secretion of IT patients was increased and delayed during OGTT. Interestingly, the insulin release during arginine load was significantly decreased in NT and IT as well as in DM patients. The GH response to OGTT was altered in IT patients. Plasma glucagon after an arginine load was significantly higher in patients than in controls. The results indicate that FA is associated with insulin resistance, 
-cell deficiency, and type I diabetes. These alterations might be genetically linked or metabolically related to the primary defect in FA. Their interplay or independent effects are responsible for abnormalities of glucose metabolism in FA.
Address correspondence and reprint requests to Dr. Finocchiaro, Laboratorio di Biochimica e Genetica, Istituto Neurologico, via Celoria 11, 20133 Milano, Italy.
Received September 2, 1987. Accepted for publication in final form December 9, 1987.
This article has been cited by other articles:
|
|
 |
|
  F. Auchere, R. Santos, S. Planamente, E. Lesuisse, and J.-M. Camadro Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia Hum. Mol. Genet., September 15, 2008; 17(18): 2790 - 2802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R Maring and E. Croarkin Presentation and Progression of Friedreich Ataxia and Implications for Physical Therapist Examination Physical Therapy, December 1, 2007; 87(12): 1687 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shan, E. Napoli, and G. Cortopassi Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones Hum. Mol. Genet., April 15, 2007; 16(8): 929 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Simon, H. Seznec, A. Gansmuller, N. Carelle, P. Weber, D. Metzger, P. Rustin, M. Koenig, and H. Puccio Friedreich Ataxia Mouse Models with Progressive Cerebellar and Sensory Ataxia Reveal Autophagic Neurodegeneration in Dorsal Root Ganglia J. Neurosci., February 25, 2004; 24(8): 1987 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Karthikeyan, L. K. Lewis, and M. A. Resnick The mitochondrial protein frataxin prevents nuclear damage Hum. Mol. Genet., May 16, 2002; 11(11): 1351 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Puccio Recent advances in the molecular pathogenesis of Friedreich ataxia Hum. Mol. Genet., April 1, 2000; 9(6): 887 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lodi, J. M. Cooper, J. L. Bradley, D. Manners, P. Styles, D. J. Taylor, and A. H. V. Schapira Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia PNAS, September 28, 1999; 96(20): 11492 - 11495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ristow, M. F. Pfister, A. J. Yee, M. Schubert, L. Michael, C.-Y. Zhang, K. Ueki, M. D. Michael II, B. B. Lowell, and C. R. Kahn Frataxin activates mitochondrial energy conversion and oxidative phosphorylation PNAS, October 24, 2000; 97(22): 12239 - 12243. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
